Multimodality therapy for CNS nongerminoma germ cell tumors (NGGCT): Results of a phase II consortium

被引:0
|
作者
Robertson, P
Siffert, J
Jakacki, R
Hukin, J
Velasquez, L
Allen, J
机构
[1] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
[2] Beth Israel Med Ctr, New York, NY 10003 USA
[3] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA
[4] Womens & Childrens Hosp, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:465 / 465
页数:1
相关论文
共 50 条
  • [21] CNS non-germinomatous germ cell tumor (NGGCT): Lessons from the recent past
    Yeo, Kee Kiat
    MacDonald, Shannon M.
    NEURO-ONCOLOGY, 2022, 24 (11) : 1962 - 1963
  • [22] Phase II trial of primary chemotherapy followed by reduced-dose radiation for CNS germ cell tumors
    Buckner, JC
    Peethambaram, PP
    Smithson, WA
    Groover, RV
    Schomberg, PJ
    Kimmel, DW
    Raffel, C
    O'Fallon, JR
    Neglia, J
    Shaw, EG
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 933 - 940
  • [23] Role of radiation therapy (RT) in the management of CNS germ cell tumors (GCT)
    Shaw, EG
    NEURO-ONCOLOGY, 2005, 7 (04) : 533 - 533
  • [24] Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy
    Patricia L. Robertson
    Robert C. DaRosso
    Jeffrey C. Allen
    Journal of Neuro-Oncology, 1997, 32 : 71 - 80
  • [25] Combined chemotherapy and radiation therapy for CNS germ cell tumors – the Japanese experience
    Masao Matsutani
    Journal of Neuro-Oncology, 2001, 54 : 311 - 316
  • [26] Combined chemotherapy and radiation therapy for CNS germ cell tumors - the Japanese experience
    Matsutani, M
    JOURNAL OF NEURO-ONCOLOGY, 2001, 54 (03) : 311 - 316
  • [27] Improved prognosis of intracranial non-germinoma germ cell tumors with multimodality therapy
    Robertson, PL
    DaRosso, RC
    Allen, JC
    JOURNAL OF NEURO-ONCOLOGY, 1997, 32 (01) : 71 - 80
  • [28] A phase II trial of paclitaxel in refractory germ cell tumors
    Sandler, AB
    Cristou, A
    Fox, S
    Williams, SD
    Nichols, CR
    Turns, M
    Roth, BJ
    CANCER, 1998, 82 (07) : 1381 - 1386
  • [29] Phase II trial of gemcitabine in refractory germ cell tumors
    Einhorn, LH
    Stender, MJ
    Williams, SD
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) : 509 - 511
  • [30] PROGNOSTIC FACTORS OF CNS GERM CELL TUMORS; MOLECULAR AND HISTOPATHOLOGICAL ANALYSES ON 154 CASES FROM THE IGCT CONSORTIUM
    Satomi, Kaishi
    Nishikawa, Ryo
    Matsutani, Masao
    Ichimura, Koichi
    Takami, Hirokazu
    NEURO-ONCOLOGY, 2021, 23 : 124 - 125